Related Experiment Videos
Oncogenic potential of Hsp72.
1Biotechnology Center, Tufts University, Medford, Massachusetts 02155, USA.
Oncogene
|June 25, 1999
Summary
Heat shock protein 72 (Hsp72) can actively drive oncogenic transformation. Expressing Hsp72 in fibroblasts induced cancerous traits, which reversed upon its removal, highlighting Hsp72
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Heat shock protein 72 (Hsp72) is a major heat shock-inducible protein involved in cellular stress protection.
- Elevated Hsp72 levels are observed in many tumors and transformed cell lines.
- Hsp72's role in oncogenic transformation is typically considered a consequence, not a cause.
Purpose of the Study:
- To investigate the potential active role of Hsp72 in oncogenic transformation.
- To determine if Hsp72 expression can induce a transformed phenotype in non-cancerous cells.
Main Methods:
- Constitutive or adenovirus-mediated expression of Hsp72 in Rat-1 fibroblasts.
- Assessment of transformed phenotypes: loss of contact inhibition, focus formation, anchorage-independent growth, and tumor generation in mice.
- Reversal of transformed phenotype by turning off Hsp72 expression.
- Analysis of the oncogenic potential of Hsp72's peptide-binding domain.
Main Results:
- Hsp72 expression in Rat-1 fibroblasts induced oncogenic transformation, characterized by loss of contact inhibition, focus formation, and anchorage-independent growth.
- Injected Hsp72-expressing cells formed tumors in mice.
- Reversal of the transformed phenotype was observed upon cessation of Hsp72 expression.
- The peptide-binding domain of Hsp72 alone was sufficient to induce oncogenic transformation.
Conclusions:
- Hsp72 actively contributes to oncogenic transformation, rather than merely being a consequence of it.
- Hsp72 expression can confer multiple hallmarks of cancer to normal cells.
- The oncogenic potential of Hsp72 resides within its peptide-binding domain.